Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$4.5K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 1 filing we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 21 most recent Form 4 transactions.
| — |
| — |
| Open the original filing on SEC.gov |
| Jan 1 | XLO | Xilio Therapeutics, Inc. | MEXER◷ | 19,375 | — | — | +156.0% | Open the original filing on SEC.gov |
| Dec 31, 2025 | XLO | Xilio Therapeutics, Inc. | AGRANT◷◆ | 668,789 | — | — | — | Open the original filing on SEC.gov |
| Nov 21, 2025 | XLO | Xilio Therapeutics, Inc. | AGRANT◆ | 300,000 | — | — | — | Open the original filing on SEC.gov |
| Nov 21, 2025 | XLO | Xilio Therapeutics, Inc. | DTOISS◆ | 300,000 | — | — | — | Open the original filing on SEC.gov |
| Nov 21, 2025 | XLO | Xilio Therapeutics, Inc. | AGRANT◆ | 150,000 | — | — | — | Open the original filing on SEC.gov |
| Nov 21, 2025 | XLO | Xilio Therapeutics, Inc. | DTOISS◆ | 150,000 | — | — | — | Open the original filing on SEC.gov |
| Nov 21, 2025 | XLO | Xilio Therapeutics, Inc. | AGRANT◆ | 117,000 | — | — | — | Open the original filing on SEC.gov |
| Nov 21, 2025 | XLO | Xilio Therapeutics, Inc. | DTOISS◆ | 117,000 | — | — | — | Open the original filing on SEC.gov |
| Nov 21, 2025 | XLO | Xilio Therapeutics, Inc. | AGRANT◆ | 20,000 | — | — | — | Open the original filing on SEC.gov |
| Nov 21, 2025 | XLO | Xilio Therapeutics, Inc. | DTOISS◆ | 20,000 | — | — | — | Open the original filing on SEC.gov |
| Nov 21, 2025 | XLO | Xilio Therapeutics, Inc. | AGRANT◆ | 45,000 | — | — | — | Open the original filing on SEC.gov |
| Nov 21, 2025 | XLO | Xilio Therapeutics, Inc. | DTOISS◆ | 45,000 | — | — | — | Open the original filing on SEC.gov |
| Nov 21, 2025 | XLO | Xilio Therapeutics, Inc. | AGRANT◆ | 37,296 | — | — | — | Open the original filing on SEC.gov |
| Nov 21, 2025 | XLO | Xilio Therapeutics, Inc. | DTOISS◆ | 37,296 | — | — | — | Open the original filing on SEC.gov |
| Nov 21, 2025 | XLO | Xilio Therapeutics, Inc. | AGRANT◆ | 23,786 | — | — | — | Open the original filing on SEC.gov |
| Nov 21, 2025 | XLO | Xilio Therapeutics, Inc. | DTOISS◆ | 23,786 | — | — | — | Open the original filing on SEC.gov |
| Nov 21, 2025 | XLO | Xilio Therapeutics, Inc. | AGRANT◆ | 155,090 | — | — | — | Open the original filing on SEC.gov |
| Nov 21, 2025 | XLO | Xilio Therapeutics, Inc. | DTOISS◆ | 155,090 | — | — | — | Open the original filing on SEC.gov |
| Nov 21, 2025 | XLO | Xilio Therapeutics, Inc. | AGRANT◆ | 925,000 | — | — | — | Open the original filing on SEC.gov |